当前位置: 首页 > 期刊 > 《湖南中医药大学学报》 > 2022年第2期
编号:441847
化疗源性卵巢早衰的发生机制及中医药防治的研究进展
http://www.100md.com 2022年2月15日 湖南中医药大学学报 2022年第2期
不孕,中西医结合
     杨开锋 陈镇 成绍武 刘慧萍 李兰 周虹 邓桂明 肖小芹

    〔摘要〕 随着化疗在癌症中的广泛应用,患者的生存率大大提高。然而,抗癌治疗往往也是导致卵巢早衰(premature ovarian failure, POF)的重要原因。目前认为,化疗药物可以通过诱导卵巢细胞凋亡、加速原始卵泡激活、增加卵巢微血管损伤而导致原始卵泡池(primordial follicles, PMFs)减小,进而引发POF和不孕。化疗源性POF西医病机复杂,但中医药亦可从“虚”和“瘀”论治。通过归纳整理化疗药物与卵巢损伤之间的联系,运用现代科学技术研发中医药,对于预防POF和保护女性生育能力至关重要。

    〔关键词〕 卵巢早衰;化疗;不孕;发生机制;中西医结合

    〔中图分类号〕R271? ? ? ?〔文献标志码〕A? ? ? ? 〔文章编号〕doi:10.3969/j.issn.1674-070X.2022.02.028

    Research progress on the mechanism of chemotherapy-induced premature ovarian failure and the prevention and treatment with traditional Chinese medicine

    YANG Kaifeng1, CHEN Zhen2, CHENG Shaowu1, LIU Huiping1, LI Lan1, ZHOU Hong1,

    DENG Guiming1,2*, XIAO Xiaoqin1,3*

    (1. Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; 2. The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410208, China; 3. Hunan University of Technology and

    Business, Changsha, Hunan 410208, China)

    〔Abstract〕 With the widespread use of chemotherapy in cancer, the survival rate of patients has been greatly improved. However, anticancer therapy is often also an important cause of premature ovarian failure (POF). At present ......

您现在查看是摘要页,全文长 18520 字符